Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Smoller, J. W.
* Articles by Kradin, R. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Smoller, J. W.
* Articles by Kradin, R. L.
Related Collections
* Other Somatic Therapy
Psychosomatics 39:24-29, February 1998
© 1998 The Academy of Psychosomatic Medine

Sertraline Effects on Dyspnea in Patients With Obstructive Airways Disease

Jordan W. Smoller, M.D., Mark H. Pollack, M.D., David Systrom, M.D., and Richard L. Kradin, M.D.

Received October 30, 1996; revised January 29, 1997; accepted March 4, 1997. From the Department of Psychiatry and Pulmonary and Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts. Address reprint requests to Dr. Smoller, Anxiety Disorders Program, Massachusetts General Hospital, ACC–815, 15 Parkman Street, Boston, MA 02114. E-mail: smoller{at}warren.med.harvard.edu

Dyspnea can have a debilitating effect on psychosocial and physical functioning in patients with chronic obstructive airways disease. Previous research has suggested that treatment of concomitant mood or anxiety symptoms can improve dyspnea and exercise intolerance among patients with respiratory disease. The authors report here on a case series of 7 patients with obstructive airways disease who reported improvements in dyspnea after sertraline 25–100 mg/day was added to their medication regimens. Four of the seven patients did not appear to meet syndromal criteria for a mood or anxiety disorder. Subjective improvements in dyspnea may have been related to relief of mood or anxiety symptoms or to direct effects on central respiratory systems. Controlled studies are needed to clarify the potential antidyspneic effects of sertraline.

Key Words: Sertraline • Dyspnea • Obstructive Airways Disease




This article has been cited by other articles:


Home page
PsychosomaticsHome page
R. Ramasamy, T. Hildebrandt, E. O'Hea, M. Patel, L. Clemow, R. Freudenberger, and C. Skotzko
Psychological and Social Factors That Correlate With Dyspnea in Heart Failure
Psychosomatics, October 1, 2006; 47(5): 430 - 434.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
G. A. Brenes
Anxiety and Chronic Obstructive Pulmonary Disease: Prevalence, Impact, and Treatment
Psychosom Med, November 1, 2003; 65(6): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. M. Luce and J. A. Luce
Management of Dyspnea in Patients With Far-Advanced Lung Disease: "Once I Lose It, It's Kind of Hard to Catch It . . . "
JAMA, March 14, 2001; 285(10): 1331 - 1337.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1998 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org